Half Year 2025 DSM-Firmenich AG Earnings Call Transcript
Key Points
- DSM Firmenich AG (DSMFF) achieved 7% organic sales growth in the first half of 2025, with a step-up in EBITDA, indicating strong financial performance.
- The company successfully delivered on its integration synergies, achieving EUR200 million in promised synergies, with EUR100 million delivered last year and another EUR100 million this year.
- The Perfumery & Beauty segment showed continued momentum, with confidence in mid-single-digit growth for the second half of the year.
- Taste, Texture & Health business reported a 6% organic growth, driven by synergies and strong demand in Beverages and Dairy segments.
- Health Nutrition & Care segment recorded its fourth consecutive quarter of growth, supported by recovery in dietary supplements and early life nutrition, with an improving EBITDA margin.
- The cash flow was modest due to timing of payments, although the company expects to meet its cash flow target for the full year.
- The Perfumery & Beauty segment faced challenges due to destocking effects in UV filters and a force majeure impacting Aroma sales.
- Foreign exchange headwinds negatively impacted the financial results, with a EUR25 million hit in the second quarter.
- The company experienced a EUR0.30 impact on earnings per share due to a non-cash accounting adjustment related to an associate, KD Pharma.
- The Animal Nutrition & Health segment's performance was partly supported by a temporary vitamin effect, which is expected to fade in the second half.
Good morning, and thank you for joining today's call. I'm sitting here with Dimitri de Vreeze, our CEO; and Ralf Schmeitz, our CFO.
This morning, we published our first half 2025 results together with a presentation to investors, which you can find on our website. Here, you can also find our disclaimers about forward-looking statements.
Following Dimitri and Ralf's opening comments, we will open the line for questions. Importantly and as a reminder, sell-side analysts who want to ask questions will need to register via the questionerâs link, which they can find on our website in the Financial Calendar. If you have not done so yet, you can still switch now.
And with that, Dimitri, please go ahead.
Thank you, Dave, and indeed, welcome to everybody on this -- I think, very busy day for you guys. I appreciate you dialing in and I want to start with a little bit the journey we're at before
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
